<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01108328</url>
  </required_header>
  <id_info>
    <org_study_id>PGX Crossover Study</org_study_id>
    <nct_id>NCT01108328</nct_id>
  </id_info>
  <brief_title>Evaluation of Subjective Ratings of Appetite and Glucoregulation of a Low Calorie Diet Supplemented With a High Viscosity Polysaccharide (PolyGlycopleX - PGX)</brief_title>
  <official_title>A Prospective, Single Crossover, Randomized, Double Blind Placebo Controlled Trial Evaluating Subjective Ratings of Appetite and Glucoregulation of a Low Calorie Diet Supplemented With a High Viscosity Polysaccharide (PolyGlycopleX - PGX) vs. Rice Flour Control, in Overweight and Moderately Obese Females.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Canadian Center for Functional Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>InovoBiologic Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Canadian Center for Functional Medicine</source>
  <brief_summary>
    <textblock>
      The objective of the study is to compare subjective appetite ratings and after-meal and 24
      hour blood glucose levels within overweight and obese female subjects consuming either a
      standardized 3 day low calorie diet supplemented with a viscous fibre known as PGX
      (treatment) or a rice flour (placebo control). Each treatment phase will be 3 days in length
      and separated by 3 week washout phase, so subjects will also be acting as their own control.
      Subjects will be randomized to either start with the low calorie diet with PGX or the low
      calorie diet supplemented with rice flour. We hypothesize that the 3 day LCD with PGX will
      elicit an improved appetite score compared to the 3 day LCD supplemented with the rice flour
      placebo control.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the ratings of the variables in the Appetite Visual Analog Scale and the overall Appetite Score.</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in 2-hour postprandial areas under the curve (AUC) and 24 hour blood glucose (CGMS) profiles.</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Appetite and Hunger, Suppression</condition>
  <condition>Blood Glucose, Postprandial</condition>
  <arm_group>
    <arm_group_label>PolyGlycopleX (PGX)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 grams of PGX 3 times per day with each main meal (breakfast, lunch and dinner)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rice flour</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>5 grams of rice flour 3 times per day at each main meal (breakfast, lunch and dinner)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PolyGlycopleX (PGX)</intervention_name>
    <description>powder, 5 grams, 3 times per day at each main meal (breakfast, lunch and dinner) for a total of 3 days</description>
    <arm_group_label>PolyGlycopleX (PGX)</arm_group_label>
    <arm_group_label>Rice flour</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - BMI 25-35 Kg/m2

        Exclusion Criteria:

          -  Known diabetes

          -  Medications or natural health products that affect appetite

          -  Contraindications to LCD

          -  Any other medical, social or geographic condition, which, in the opinion of the
             investigator would not allow safe completion of the protocol.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Lyon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Canadian Centre for Functional Medicine</name>
      <address>
        <city>Coquitlam</city>
        <state>British Columbia</state>
        <zip>V3K6Y2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Canadian Center for Functional Medicine</name>
      <address>
        <city>Coquitlam</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Kacinik V, Lyon M, Purnama M, Reimer RA, Gahler R, Green TJ, Wood S. Effect of PGX, a novel functional fibre supplement, on subjective ratings of appetite in overweight and obese women consuming a 3-day structured, low-calorie diet. Nutr Diabetes. 2011 Dec 12;1:e22. doi: 10.1038/nutd.2011.18.</citation>
    <PMID>23154443</PMID>
  </results_reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2010</study_first_submitted>
  <study_first_submitted_qc>April 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2010</study_first_posted>
  <last_update_submitted>September 30, 2015</last_update_submitted>
  <last_update_submitted_qc>September 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>viscous</keyword>
  <keyword>fibre</keyword>
  <keyword>polysaccharide</keyword>
  <keyword>blood glucose</keyword>
  <keyword>postprandial</keyword>
  <keyword>appetite</keyword>
  <keyword>hunger</keyword>
  <keyword>satiety</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

